glp-1 in pregnancy Maternal receptor activation inhibits fetal growth GLP-1 medications like Ozempic, Wegovy

Those of you who have quit smoking know that weight gain can be a common occurrence

This helps your body stay active and prevents receptor desensitization

This combined receptor activation results in a synergistic effect on body weight reduction through increased energy expenditure, decreased food intake, delayed gastric emptying, and stimulation of lipolysis

analyzed commercial claims data (see Figure 2) and found that persistent GLP-1 users had $14K-$15K (about 14%) lower average annual total cost of care in the first one to two years of use compared with chronically obese patients who never tried GLP-1s

Retatrutide belongs to a new class of incretin-based therapies that expands on the success of medications like Ozempic and Mounjaro